STOCK CONTRIBUTION AGREEMENTStock Contribution Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis Stock Contribution Agreement (this “Agreement”), dated as of June 19, 2012, is entered into by and among FINESCO, a holding company incorporated in France (“Finesco”); SCOMEDICA, a company incorporated in France (“Scomedica”) (collectively, Finesco and Scomedica shall be hereinafter referred to as the “Companies”), MR. GERARD BURGER, a French citizen (“Mr. Burger”), MRS. MARTINE BURGER, a French citizen (“Mrs. Burger”), MR. RACHED GAIDA, a French citizen (“Mr. Gaida”), MR. ERIC DIALLO, a French citizen (“Mr. Diallo”) and MRS. DOMINIQUE BAPTISTE, a French citizen (“Mrs. Baptiste”) (Mr. Gaida, Mr. Diallo and Mrs. Baptiste collectively shall be referred to hereinafter as the “Minority Shareholders”) (Mr. Burger, Mrs. Burger and the Minority Shareholders collectively shall be referred to hereinafter as the “Contributors”), and APRICUS BIOSCIENCES, INC., a Nevada corporation (“Beneficiary”) (each a “Party” and collectively, Finesco, Scomedica, the Contributors and the Beneficiary shall
STOCK CONTRIBUTION AGREEMENTStock Contribution Agreement • July 13th, 2012 • Apricus Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 13th, 2012 Company Industry JurisdictionThis Stock Contribution Agreement (this “Agreement”), dated as of June 19, 2012, is entered into by and among FINESCO, a holding company incorporated in France (“Finesco”); SCOMEDICA, a company incorporated in France (“Scomedica”) (collectively, Finesco and Scomedica shall be hereinafter referred to as the “Companies”), MR. GERARD BURGER, a French citizen (“Mr. Burger”), MRS. MARTINE BURGER, a French citizen (“Mrs. Burger”), MR. RACHED GAIDA, a French citizen (“Mr. Gaida”), MR. ERIC DIALLO, a French citizen (“Mr. Diallo”) and MRS. DOMINIQUE BAPTISTE, a French citizen (“Mrs. Baptiste”) (Mr. Gaida, Mr. Diallo and Mrs. Baptiste collectively shall be referred to hereinafter as the “Minority Shareholders”) (Mr. Burger, Mrs. Burger and the Minority Shareholders collectively shall be referred to hereinafter as the “Contributors”), and APRICUS BIOSCIENCES, INC., a Nevada corporation (“Beneficiary”) (each a “Party” and collectively, Finesco, Scomedica, the Contributors and the Beneficiary shall